机构:[1]Department of Sociology, Shenzhen University, Shenzhen, China深圳市康宁医院深圳医学信息中心[2]Center for Biomedical Information Technology,Shenzhen Institutes of Advanced Technology, Shenzhen, China
Background Regularly updated data on stroke and its pathological types, including data on their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are important for evidence-based stroke care planning and resource allocation. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) aims to provide a standardised and comprehensive measurement of these metrics at global, regional, and national levels. Methods We applied GBD 2019 analytical tools to calculate stroke incidence, prevalence, mortality, disability-adjusted life-years (DALYs), and the population attributable fraction (PAF) of DALYs (with corresponding 95% uncertainty intervals [UIs]) associated with 19 risk factors, for 204 countries and territories from 1990 to 2019. These estimates were provided for ischaemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, and all strokes combined, and stratified by sex, age group, and World Bank country income level. Findings In 2019, there were 12.2 million (95% UI 11.0-13.6) incident cases of stroke, 101 million (93.2-111) prevalent cases of stroke, 143 million (133-153) DALYs due to stroke, and 6.55 million (6.00-7.02) deaths from stroke. Globally, stroke remained the second-leading cause of death (11.6% [10.8-12.2] of total deaths) and the third-leading cause of death and disability combined (5.7% [5.1-6.2] of total DALYs) in 2019. From 1990 to 2019, the absolute number of incident strokes increased by 70.0% (67.0-73.0), prevalent strokes increased by 85.0% (83.0-88.0), deaths from stroke increased by 43.0% (31.0-55.0), and DALYs due to stroke increased by 32.0% (22.0-42.0). During the same period, age-standardised rates of stroke incidence decreased by 17.0% (15.0-18.0), mortality decreased by 36.0% (31.0-42.0), prevalence decreased by 6.0% (5.0-7.0), and DALYs decreased by 36.0% (31.0-42.0). However, among people younger than 70 years, prevalence rates increased by 22.0% (21.0-24.0) and incidence rates increased by 15.0% (12.0-18.0). In 2019, the age-standardised stroke-related mortality rate was 3.6 (3.5-3.8) times higher in the World Bank low-income group than in the World Bank high-income group, and the age-standardised stroke-related DALY rate was 3.7 (3.5-3.9) times higher in the low-income group than the high-income group. Ischaemic stroke constituted 62.4% of all incident strokes in 2019 (7.63 million [6.57-8.96]), while intracerebral haemorrhage constituted 27.9% (3.41 million [2.97-3.91]) and subarachnoid haemorrhage constituted 9.7% (1.18 million [1.01-1.39]). In 2019, the five leading risk factors for stroke were high systolic blood pressure (contributing to 79.6 million [67.7-90.8] DALYs or 55.5% [48.2-62.0] of total stroke DALYs), high body-mass index (34.9 million [22.3-48.6] DALYs or 24.3% [15.7-33.2]), high fasting plasma glucose (28.9 million [19.8-41.5] DALYs or 20.2% [13.8-29.1]), ambient particulate matter pollution (28.7 million [23.4-33.4] DALYs or 20.1% [16.6-23.0]), and smoking (25.3 million [22.6-28.2] DALYs or 17.6% [16.4-19.0]). Interpretation The annual number of strokes and deaths due to stroke increased substantially from 1990 to 2019, despite substantial reductions in age-standardised rates, particularly among people older than 70 years. The highest age-standardised stroke-related mortality and DALY rates were in the World Bank low-income group. The fastest-growing risk factor for stroke between 1990 and 2019 was high body-mass index. Without urgent implementation of effective primary prevention strategies, the stroke burden will probably continue to grow across the world, particularly in low-income countries.
基金:
Bill AMP; Melinda Gates FoundationCGIAR; Monash UniversityMonash University; Alexander von Humboldt Foundation through the Alexander von Humboldt Professor award - German Federal Ministry of Education and Research; National Institute of Health Research (NIHR) Oxford Biomedical Research CentreNational Institute for Health Research (NIHR); Portuguese national funds through Fundacao para a Ciencia e Tecnologia (FCT), IP, under the Norma Transitoria [SFRH/BHD/110001/2015, DL57/2016/CP1334/CT0006]; National Institute for Health Research (NIHR) Applied Research Collaboration (ARC) South London at King's College Hospital NHS Foundation Trust; Royal College of Physicians; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College LondonGeneral Electric; Brazilian National Council for Scientific and Technological Development (CNPq, research fellowship)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF); Institute for Health Technology Assessment (IATS) [465518/2014-1]; Novo Nordisk FoundationNovo Nordisk FoundationNovocure Limited [NNF16OC0021856]; Fondazione Umberto VeronesiFondazione Umberto Veronesi; NIHR Applied Research Collaboration West Midlands; National Health and Medical Research Council (NHMRC), AustraliaNational Health and Medical Research Council of Australia; NHMRC and National Heart Foundation of Australia Fellowships; Wellcome Trust/DBT India Alliance Clinical and Public Health Intermediate Fellowship [IA/CPHI/14/1/501497]; Research Management Centre, Xiamen University Malaysia [XMUMRF-C6/ITCM/0004]; Manipal Academy of Higher Education; UGC Centre of Advanced Study (Phase II); UK Biobank, University of Oxford; Academy of FinlandAcademy of FinlandEuropean Commission [330527]; German Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF) [01EA1808A]; Italian Ministry of Health Ricerca Corrente -IRCCS MultiMedica; National Institute for Health Research Biomedical Research Center at Guy's and St Thomas' National Health Service Foundation Trust; Fogarty International Center of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [K43TW010704]; NIH under the H3Africa initiativeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [SIREN U54 HG007479]; SIBS Genomics [R01NS107900]; SIBS Gen Gen [R01NS107900-02S1]; ARISES [R01NS115944]; H3Africa CVD Supplement [3U24HG009780-03S5]; CaNVAS [1R01NS114045]; Romanian National Authority for Scientific Research and Innovation, CNDS-UEFISCDIConsiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI) [N-III-P4-ID-PCCF-2016-0084]; Italian Ministry of HealthMinistry of Health, Italy; Egyptian Fulbright Mission Program; Shenzhen Science and Technology Program [KQTD20190929172835662]; Health Data Research UK; David Freeze Chair in Health Research (University of Calgary); Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal; Department of Medicine, University of Rajarata, Sri Lanka; National Heart Foundation of Australia post-doctoral fellowshipNational Heart Foundation of Australia; Australian Government research training program (RTP); Science and Technology Research Project of Hubei Provincial Department of Education [Q20201104]; Open Fund Project of Hubei Province Key Laboratory of Occupational Hazard Identification and Control [OHIC2020Y01]; [IA/CPHI/14/1/501514]
第一作者机构:[1]Department of Sociology, Shenzhen University, Shenzhen, China
通讯作者:
通讯机构:[*1]National Institute for Stroke and Applied Neurosciences, Faculty of Health and Environmental Sciences, Auckland University of Technology, Northcote, Auckland 0627, New Zealand
推荐引用方式(GB/T 7714):
Li Bingyu,Sha Feng,Valery L Feigin.Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J].LANCET NEUROLOGY.2021,20(10):795-820.doi:10.1016/S1474-4422(21)00252-0.
APA:
Li, Bingyu,Sha, Feng&Valery L Feigin.(2021).Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.LANCET NEUROLOGY,20,(10)
MLA:
Li, Bingyu,et al."Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019".LANCET NEUROLOGY 20..10(2021):795-820